Pegvisomant - Somavert; Somatropin antagonist, pegylated, recombinant -- Product Record

Somatropin antagonist, rDNA, PEG-

    Nomenclature:
      Somatropin antagonist, rDNA, PEG- [BIO]
      Somavert [TR]
      pegvisomant [FDA INN]
      somatotropin [18-aspartic acid, 21-asparagine, 120-lysine, 167-asparagine, 168-alanine, 171-serine, 172-arginine, 174-serine, 179-threonine] (human), pegylated [CAS]
      B-2036 [SY]
      B2036-PEG [SY]
      human growth hormone antagonist, PEG-, rDNA [SY]
      PEG-B2036 [SY]
      PNU-467-MET-0435 [SY]
      somatropin antagonist, pegylated, recombinant [SY]
      Trovert [SY]
      NDC 0009-5176-01 [NDC]
      NDC 0009-5178-01 [NDC]
      NDC 0009-5180-01 [NDC]

    molecular weight (kDa) = 22

    FDA Class:  NDA Drug

    Year of approval (FDA) = 2003